The ulcer is significantly shallower and smaller, often appearing as a thin, linear ulcer or a small spot, showing substantial regeneration. Scar Stage (S1, S2)
If used as a syndrome or condition in a story:
The ulcer floor is covered heavily by a thick, deep-seated layer of white or yellowish-gray exudate (necrotic slough). The surrounding mucosal margins are prominently edematous, hyperemic, and lack any signs of epithelial regeneration. Thrombi or exposed, pulsating blood vessels may be visibly projecting through the exudative base.
Slough becomes thinner; regenerative epithelium begins to appear. sakitamiwa classification
is typically used to assess the risk of active bleeding or rebleeding. PubMed Central (PMC) (.gov) medications typically prescribed for ulcers in these different stages?
Track the progress of treatment (e.g., using Proton Pump Inhibitors) over time.
In this phase, the body begins to repair the damage and "fill in" the crater. The ulcer is significantly shallower and smaller, often
In local classification systems, diseases are often categorized by:
The ulcer is deep, covered with a thick white or yellow coating (slough), and the surrounding tissue (gastric wall) is significantly swollen and reddened. A2 (Active 2):
– Possibly in fields like traditional medicine, botany, or library science in Japanese or another language. Thrombi or exposed, pulsating blood vessels may be
: The redness fades, and the area becomes a white scar as the mucosa fully matures. Clinical Importance Healing Assessment
The edema at the ulcer margin begins to subside, and the "lip-like sign" is less prominent. The ulcer base remains covered with slough. 2. Healing Stage (Stage H)
The represents a sophisticated attempt to bring precision, reproducibility, and prognostic clarity to complex disease grading. Whether you are a clinician interpreting a report, a researcher designing a trial, or a student preparing for board exams, understanding this 5-tier system (Sak-N through Sak-D) is essential for modern practice. While it is not a universal tool for all diseases, in its specific domain, the Sakitamiwa system remains the gold standard—one that continues to evolve with the frontiers of molecular and digital pathology.